| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the A. W. Morrow Gastroenterology and Liver Centre,Centenary Institute of Cancer Medicine and Cell Biology, Royal PrinceAlfred Hospital*
and The University ofSydney,
Sydney, Australia
The pathogenesis of hepatitis C virus (HCV)-associated liver injury involves many genes from multiple pathogenic pathways. cDNA array analysis, which examines the expression of many genes simultaneously, was used to achieve new insights into HCV liver injury. Membrane-based cDNA arrays of 874 genes compared HCV-associated cirrhosis with autoimmune hepatitis-associated cirrhosis as an inflammatory and cirrhotic control, and with nondiseased liver tissue. Array analysis identified many differentially expressed genes that are important in inflammation, fibrosis, proliferation, signaling, apoptosis, and oxidative stress. Genes up-regulated in HCV-associated cirrhosis were predominantly associated with a Th1 immune response, fibrosis, cellular proliferation, and apoptosis. Novel observations of differential gene expression included increased expression of secreted apoptosis-related protein 3, a Wnt pathway gene possibly involved in cellular apoptosis. EMMPRIN (CD147) and discoidin domain receptor 1 (CD167) were also shown to be increased and are likely to play a role in liver fibrosis. Real-time quantitative reverse transcriptase-polymerase chain reaction confirmed the increased expression of 15 genes. The comparison of HCV cirrhosis with autoimmune hepatitis cirrhosis showed a marked difference in the apoptosis-associated gene profile with HCV cirrhosis characterized by increased proapoptotic gene expression whereas autoimmune hepatitis was characterized by increased expression of both antiapoptotic and proapoptotic genes. Furthermore, expressionof ß-catenin and the fibrosis-associated protein EMMPRIN were localized by immunohistochemistry to the plasma membranes of hepatocytes and biliary epithelium. In conclusion, HCV-associated cirrhosis was characterized by a proinflammatory, profibrotic, and proapoptotic gene expression profile.
This article has been cited by other articles:
 |
|
 |
|
  M. B. Miller and Y.-W. Tang Basic Concepts of Microarrays and Potential Applications in Clinical Microbiology Clin. Microbiol. Rev., October 1, 2009; 22(4): 611 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Huet, B. Vallee, D. Szul, F. Verrecchia, S. Mourah, J. V. Jester, T. Hoang-Xuan, S. Menashi, and E. E. Gabison Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing {alpha}-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling FASEB J, April 1, 2008; 22(4): 1144 - 1154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Friedman Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver Physiol Rev, January 1, 2008; 88(1): 125 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kim, J. W. Yoon, X. Xiao, N. M. Dean, B. P. Monia, and E. G. Marcusson Selective Down-Regulation of Glioma-Associated Oncogene 2 Inhibits the Proliferation of Hepatocellular Carcinoma Cells Cancer Res., April 15, 2007; 67(8): 3583 - 3593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Sicklick, Y.-X. Li, A. Jayaraman, R. Kannangai, Y. Qi, P. Vivekanandan, J. W. Ludlow, K. Owzar, W. Chen, M. S. Torbenson, et al. Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis Carcinogenesis, April 1, 2006; 27(4): 748 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Zekry, J G McHutchison, and A M Diehl Insulin resistance and steatosis in hepatitis C virus infection Gut, July 1, 2005; 54(7): 903 - 906. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Sunman, R. L. Hawke, E. L. LeCluyse, and A. D. M. Kashuba KUPFFER CELL-MEDIATED IL-2 SUPPRESSION OF CYP3A ACTIVITY IN HUMAN HEPATOCYTES Drug Metab. Dispos., March 1, 2004; 32(3): 359 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G W McCaughan and J George Fibrosis progression in chronic hepatitis C virus infection Gut, March 1, 2004; 53(3): 318 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Seth, M. A. Leo, P. H. McGuinness, C. S. Lieber, Y. Brennan, R. Williams, X. M. Wang, G. W. McCaughan, M. D. Gorrell, and P. S. Haber Gene Expression Profiling of Alcoholic Liver Disease in the Baboon (Papio hamadryas) and Human Liver Am. J. Pathol., December 1, 2003; 163(6): 2303 - 2317. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Betsuyaku, M. Tanino, K. Nagai, Y. Nasuhara, M. Nishimura, and R. M. Senior Extracellular Matrix Metalloproteinase Inducer Is Increased in Smokers' Bronchoalveolar Lavage Fluid Am. J. Respir. Crit. Care Med., July 15, 2003; 168(2): 222 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Betsuyaku, K. Kadomatsu, G. L. Griffin, T. Muramatsu, and R. M. Senior Increased Basigin in Bleomycin-Induced Lung Injury Am. J. Respir. Cell Mol. Biol., May 1, 2003; 28(5): 600 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chilosi, V. Poletti, A. Zamo, M. Lestani, L. Montagna, P. Piccoli, S. Pedron, M. Bertaso, A. Scarpa, B. Murer, et al. Aberrant Wnt/{beta}-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis Am. J. Pathol., May 1, 2003; 162(5): 1495 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Ansell, M. J. Ackerman, J. L. Black, L. R. Roberts, and A. Tefferi Primer on Medical Genomics Part VI: Genomics and Molecular Genetics in Clinical Practice Mayo Clin. Proc., March 1, 2003; 78(3): 307 - 317. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
